Yang Yaling, Jiang Rui, He Taiwen, Lu Hongzhou, Zhang Renfang, Shen Yinzhong, Zheng Yufang, Liu Li, Wang Wenji
Shanghai Public Health Clinical Center, Shanghai 201508, China.
Email:
Zhonghua Yan Ke Za Zhi. 2014 Mar;50(3):197-202.
To investigate the clinical characteristics of cytomegalovirus retinitis (CMVR) in acquired immunodeficiency syndrome (AIDS) patients.
Retrospective case-series study. The clinical and laboratory data of 80 AIDS patients (118 eyes) with findings of CMVR were collected from Shanghai Public Health Clinical Center from December 2006 to December 2011. The relationship between CMVR and cellular immunity, the high risk factor, clinical characteristics, treatment and prognosis of CMVR were analyzed in this study. χ(2) test was used to check the incidence of CMVR in different CD4(+) T lymphocyte count groups.
There was 80 AIDS patients (118 eyes) totally, 71 males and 9 females. Their age was from 18 to 60 years old, which mean value was (38 ± 10) years old. The incidence in the group of CD4(+) T lymphocyte count over 100 cells/µl was lower than the two groups of CD4(+) T lymphocyte count less than 100 cells/µl (χ(2) = 15.567, 32.469; P = 0.00,0.00). CD4(+) T lymphocyte count was always ranged from 0 to 141 cells/µl in CMVR patients. It was less than 50 cells/µl in 81.3% cases. In 10.0% AIDS patients, CMVR was the first manifestation. In 25% AIDS patients(26 eyes), lesions in retina was found by routine eye examination. In 54.2% patients, the best corrected visual acuity was less than 0.3. Retinal necrosis was involvement near the posterior pole in 62.5% CMVR patients. The visual acuity of 51 eyes was improved after treatment within 94.1% cases which were treated within 3 months. However, BCVA of 35 eyes decreased or with less change within 42.9% cases which were treated after symptoms appeared 3 months. The anti-CMV treatment included induction and maintenance of ganciclovir or foscarnet stopped when the CD4(+)T lymphocyte count was more than 150 cells/µl in 3 continuous months. 86.9% eyes were cured clinically. Retinal detachment, immune reconstitution uveitis and complicated cataract was found in 13.1%, 12.1% and 20.5% cases respectively. Optic atrophy occurred in 6 eyes. The visual acuity of 28.9% eyes was 0.05 or less, 71.3% of that caused by retinal detachment, cataract and optic atrophy.
CD4(+) T lymphocyte count reduction is the risk factor for CMVR. HAART and anti-CMV therapy will cure the CMVR clinically.Routine eye examinations should be performed in all AIDS patients to get early diagnosis of CMVR or other opportunistic infections to avoid vision loss, especially in those CD4(+) T lymphocyte count lower than 100 cells/µl.
探讨获得性免疫缺陷综合征(AIDS)患者巨细胞病毒性视网膜炎(CMVR)的临床特征。
回顾性病例系列研究。收集2006年12月至2011年12月期间在上海公共卫生临床中心确诊为CMVR的80例AIDS患者(118只眼)的临床及实验室资料,分析CMVR与细胞免疫的关系、高危因素、临床特征、治疗及预后。采用χ(2)检验比较不同CD4(+)T淋巴细胞计数组CMVR的发生率。
共80例AIDS患者(118只眼),男71例,女9例,年龄18~60岁,平均(38±10)岁。CD4(+)T淋巴细胞计数>100个/μl组CMVR发生率低于CD4(+)T淋巴细胞计数<100个/μl的两组(χ(2)=15.567、32.469;P=0.00、0.00)。CMVR患者CD4(+)T淋巴细胞计数始终在0~141个/μl,81.3%的病例低于50个/μl。10.0%的AIDS患者以CMVR为首发表现。25%的AIDS患者(26只眼)经常规眼科检查发现视网膜病变。54.2%的患者最佳矫正视力<0.3。62.5%的CMVR患者视网膜坏死累及后极附近。3个月内接受治疗的患者中,94.1%(51只眼)治疗后视力提高;症状出现3个月后接受治疗的患者中,42.9%(35只眼)最佳矫正视力下降或变化不大。抗CMV治疗采用更昔洛韦或膦甲酸钠诱导及维持治疗,当CD4(+)T淋巴细胞计数连续3个月>150个/μl时停药。86.9%的患眼临床治愈。分别有13.1%、12.1%和20.5%的病例发生视网膜脱离、免疫重建葡萄膜炎和并发性白内障。6只眼发生视神经萎缩。28.9%患眼视力≤0.05,其中71.3%由视网膜脱离、白内障和视神经萎缩所致。
CD4(+)T淋巴细胞计数降低是CMVR的危险因素。高效抗逆转录病毒治疗(HAART)联合抗CMV治疗可使CMVR临床治愈。所有AIDS患者均应进行常规眼科检查,以便早期诊断CMVR或其他机会性感染,避免视力丧失,尤其是CD4(+)T淋巴细胞计数<100个/μl的患者。